COCP

Cocrystal Pharma, Inc. is a clinical-stage biotechnology company focused on discovering and developing antiviral therapeutics targeting the replication machinery of various viruses, including coronaviruses, influenza, and noroviruses. The company employs structure-based drug design technologies to create novel small molecule therapeutics. Cocrystal operates primarily in the United States and is advancing multiple antiviral candidates through clinical trials, including treatments for pandemic and seasonal influenza as well as norovirus infections.